Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-24 @ 12:46 PM
NCT ID:
NCT03745261
Eligibility Criteria:
Inclusion Criteria:
* A confirmed diagnosis of mild to severe COPD.
* Medically stable.
* Syndrome differentiation belongs to syndrome of insufficiency of qi of the lung and kidney.
* Age between 18 and 80 years.
* With the informed consent signed.
Exclusion Criteria:
* Pregnant or breast-feeding women.
* Current respiratory disorders other than COPD (e.g., bronchiectasis, bronchial asthma, tuberculosis, lung fibrosis, pulmonary thromboembolic, diffuse panbronchiolitis, lung cancer).
* Complicated with heart failure (NYHA Class III or IV), or myocardial infarction within six months ,or unstable hemodynamics.
* Complicated with serious hepatic and renal diseases (liver cirrhosis, portal hypertension, bleeding of varicose veins, dialysis, or renal transplantation).
* Any psychiatric condition rendering the patient unable to understand the nature, scope and possible consequences of the study.
* Participating in other trials or allergic to the used medicine.
* Participating in other clinical trials with other interventions in one month.
* Allergic to the used medicine.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03745261
Study Brief:
Protocol Section:
NCT03745261